PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025
PacBio (PACB) has scheduled its fourth quarter 2024 financial results conference call for Thursday, February 13, 2025, at 4:30 pm Eastern Time (1:30 pm Pacific Time). Investors and interested parties can access the webcast through PacBio's investor relations website. For those preferring to dial in, toll-free and international numbers are available, and participants are advised to join ten minutes before the start time.
PacBio (PACB) ha programmato la sua telefonata per i risultati finanziari del quarto trimestre 2024 per giovedì 13 febbraio 2025, alle 16:30 ora orientale (13:30 ora del Pacifico). Gli investitori e le parti interessate possono accedere al webcast tramite il sito delle relazioni con gli investitori di PacBio. Per coloro che preferiscono partecipare telefonicamente, sono disponibili numeri verdi e internazionali, e si consiglia ai partecipanti di unirsi dieci minuti prima dell'orario di inizio.
PacBio (PACB) ha programado su conferencia de resultados financieros del cuarto trimestre 2024 para el jueves 13 de febrero de 2025 a las 4:30 p.m. hora del este (1:30 p.m. hora del pacífico). Los inversionistas y partes interesadas pueden acceder a la transmisión web a través del sitio web de relaciones con inversionistas de PacBio. Para aquellos que prefieren marcar, hay disponibles números gratuitos e internacionales, y se aconseja a los participantes unirse diez minutos antes de la hora de inicio.
PacBio (PACB)는 2025년 2월 13일 목요일 오후 4시 30분(동부 표준시)에 2024년 4분기 재무 결과에 대한 전화 회의를 예정하고 있습니다(태평양 표준시 오후 1시 30분). 투자자 및 관련자는 PacBio의 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있습니다. 전화로 참여를 원하는 분들을 위해 무료 및 국제 전화번호가 제공되며, 참가자는 시작 시간 10분 전에 접속할 것을 권장합니다.
PacBio (PACB) a prévu sa conférence téléphonique sur les résultats financiers du quatrième trimestre 2024 pour jeudi 13 février 2025 à 16h30 heure de l'Est (13h30 heure du Pacifique). Les investisseurs et les parties intéressées peuvent accéder au webinaire via le site web des relations avec les investisseurs de PacBio. Pour ceux qui préfèrent se connecter par téléphone, des numéros gratuits et internationaux sont disponibles, et il est conseillé aux participants de se joindre dix minutes avant l'heure de début.
PacBio (PACB) hat seine Telefonkonferenz zu den Finanzergebnissen des vierten Quartals 2024 für Donnerstag, den 13. Februar 2025, um 16:30 Uhr Eastern Time (13:30 Uhr Pazifische Zeit) angesetzt. Investoren und Interessierte können über die Investor-Relations-Website von PacBio auf das Webcast zugreifen. Für diejenigen, die lieber anrufen möchten, sind gebührenfreie und internationale Telefonnummern verfügbar, und die Teilnehmer werden gebeten, zehn Minuten vor Beginn zu erscheinen.
- None.
- None.
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, 2025, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, February 13, 2025, at 4:30 pm ET (1:30 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please join the call ten minutes before the start time using the appropriate number above and ask to join the “PacBio Q4 Earnings Call.”
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (PACB) report Q4 2024 earnings?
How can investors access PacBio's (PACB) Q4 2024 earnings call?
What time should participants join PacBio's (PACB) Q4 2024 earnings call?
Will there be a replay available for PacBio's (PACB) Q4 2024 earnings call?
